Metagenomics Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2031 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa)

Description

The metagenomics market is experiencing unprecedented growth, driven by technological advancements, increasing awareness of genetic disorders, and the introduction of new bioinformatic tools. Metagenomics, a high-throughput screening tool for microbial communities, is revolutionizing the study of genetic material recovered from environmental samples, offering promising opportunities in pharmaceutical and industrial product development.

Analysis of Genes and Metabolic Pathways

Metagenomics experiments primarily aim to analyze genes and study metabolic pathways within microbial communities. This innovative approach opens doors to exploring new pharmaceutical and industrial products sourced from the environment. Additionally, it delves into the composition and taxonomy of microbial cultures.

Key Players and Market Expansion

Leading manufacturers in the metagenomics market, including GE Healthcare, Thermo Fischer Scientific, Inc., Danaher, and Merck KGaA, are actively introducing new products and pursuing mergers and acquisitions to expand their portfolios. Collaborative efforts and distribution channel expansion in emerging countries are also priorities for these companies. Many are planning to invest in new facilities to boost production capacity.

Growing Awareness of Genetic Disorders

Increasing awareness of genetic disorders worldwide, particularly in clinical diagnostics, is a driving force behind the metagenomics market's growth. Genetic abnormalities and diseases, along with governmental support for genetics research, sophisticated infrastructure, and the presence of advanced bioinformatics tools, are contributing to the market's expansion.

New Bioinformatic Tools and Research Laboratories

Technological advancements have led to the introduction of new bioinformatics tools, enhancing the revenue potential of the metagenomics market. Improved genomic tools and advanced technological platforms are key growth drivers. The development of research laboratories and the introduction of microarrays in diagnostics are increasing the diagnosis rate of genetic disorders.

Environmental Toxicology and Bioremediation

Metagenomics plays a crucial role in environmental toxicology and bioremediation by aiding in the study of microorganisms responsible for the degradation of environmental pollutants. Understanding the impact of contaminants and treatments on complex microbial communities is vital.

New Products, Techniques, and Genome Projects

Companies are actively developing new sequencing products, aiming to expand their portfolios and revenue. Advancements in bioinformatics programming have enabled 3D metagenomics experiments, offering new insights into interactions between phages and bacteria. The introduction of various genome projects is creating databases for research and developmental activities.

Competitive Analysis

The competitive landscape section of the report provides insights into prominent players in the market, highlighting their market shares, distinctive strategies, product portfolios, marketing approaches, and company performance indicators. Among the key players featured in the report are Illumina Inc, Thermo Fisher Scientific, Trivitron Healthcare, Qiagen, Symbio Scientific Pvt Ltd., Infobio, Bio-Rad Laboratories, Merck KgaA, Promega Corporation, and PerkinElmer Inc.

Thermo Fisher Scientific and Qiagen both offer a diverse range of products for metagenomics, encompassing various DNA extraction kits and related solutions. Merck KgaA specializes in the production of DNA polymerases, a critical component for DNA fragment sequencing.

Leading manufacturers in the metagenomics field are actively engaged in the development of innovative sequencing kits. Additionally, they are strategically expanding their presence in emerging markets, such as South America and Eastern Europe. Mergers and partnerships are a prevalent strategy for growth in the metagenomics market.

Market Segmentation

The report provides a comprehensive segmentation of the metagenomics market based on several key factors, including product types, applications, end users, and geographic regions.

In the metagenomics market, three primary types of kits are prominently utilized. These kits include:

1. Library Preparation Kits: These kits are designed for the preparation of nucleic acid targets through a series of enzymatic reactions.
2. Sample Extraction Kits: These kits are employed to extract genomic DNA from a wide variety of sources, such as cells and tissues.
3. Metagenomic Sequencing Kits: These kits are utilized for the sequencing of DNA fragments in metagenomic studies.

Metagenomics finds applications in diverse fields, including:

Microbial Diversity Analysis
Bioremediation
Production of Bio-surfactants and Antibiotics
Clinical Diagnostics

Clinical diagnostics is expected to hold a significant share in the metagenomics market.

The end-user segments within the metagenomics market encompass:

Pharmaceutical Industries
Hospitals
Academic and Research Institutes
Research Laboratories
Others, such as Clinics and Emergency Services

Furthermore, the metagenomics market has been analyzed across various geographical regions, including:

North America
Latin America
Europe
Asia Pacific (Excluding Japan)
Japan
Middle East and Africa (MEA)

1. Executive Summary

1.1. Global Metagenomics Market Snapshot
1.2. Future Projections
1.3. Key Market Trends
1.4. Regional Snapshot, by Value and Volume, 2023
1.5. Analyst Recommendations

2. Market Overview

2.1. Market Definitions and Segmentations
2.2. Market Dynamics
- 2.2.1. Drivers
- 2.2.2. Restraints
- 2.2.3. Market Opportunities
2.3. Value Chain Analysis
2.4. Porter's Five Forces Analysis
2.5. COVID-19 Impact Analysis
- 2.5.1. Supply
- 2.5.2. Demand
2.6. Impact of Ukraine-Russia Conflict
2.7. Economic Overview
- 2.7.1. World Economic Projections
2.8. PESTLE Analysis

3. Production Output and Trade Statistics, 2018 - 2023

3.1. Global Metagenomics Production Output, by Region, Value (US$ Mn) and Volume (Units), 2018 - 2023
- 3.1.1. North America
- 3.1.2. Europe
- 3.1.3. Asia Pacific
- 3.1.4. Latin America
- 3.1.5. Middle East and Africa

4. Price Analysis, 2018 - 2023

4.1. Global Average Price Analysis by Product Type, 2018 - 2023
4.2. Prominent Factor Affecting Metagenomics Prices
4.3. Global Average Price Analysis by Region

5. Global Metagenomics Market Outlook, 2018 - 2031

5.1. Global Metagenomics Market Outlook, by Product Types, Value (US$ Mn) and Volume (Units), 2018 - 2031
- 5.1.1. Key Highlights
  - 5.1.1.1. Library Preparation Kits
  - 5.1.1.2. Sample Extraction Kits
  - 5.1.1.3. Metagenomic Sequencing Kits
5.2. Global Metagenomics Market Outlook, by Application, Value (US$ Mn) and Volume (Units), 2018 - 2031
- 5.2.1. Key Highlights
  - 5.2.1.1. Microbial Diversity
  - 5.2.1.2. Bioremediation and degradation
  - 5.2.1.3. Bio surfactants and Antibiotics Production
  - 5.2.1.4. Clinical Diagnostics
  - 5.2.1.5. Others
5.3. Global Metagenomics Market Outlook, by End User, Value (US$ Mn) and Volume (Units), 2018 - 2031
- 5.3.1. Key Highlights
  - 5.3.1.1. Pharmaceutical Industries
  - 5.3.1.2. Research Laboratories
  - 5.3.1.3. Biotechnology Companies
  - 5.3.1.4. Pathology Laboratories
  - 5.3.1.5. Academic and Research Laboratories
  - 5.3.1.6. Hospitals
  - 5.3.1.7. Others (Environmental institutes, chemical companies etc.)
5.4. Global Metagenomics Market Outlook, by Region, Value (US$ Mn) and Volume (Units), 2018 - 2031
- 5.4.1. Key Highlights
  - 5.4.1.1. North America
  - 5.4.1.2. Europe
  - 5.4.1.3. Asia Pacific
  - 5.4.1.4. Latin America
  - 5.4.1.5. Middle East & Africa

6. North America Metagenomics Market Outlook, 2018 - 2031

6.1. North America Metagenomics Market Outlook, by Product Types, Value (US$ Mn) and Volume (Units), 2018 - 2031
- 6.1.1. Key Highlights
  - 6.1.1.1. Library Preparation Kits
  - 6.1.1.2. Sample Extraction Kits
  - 6.1.1.3. Metagenomic Sequencing Kits
6.2. North America Metagenomics Market Outlook, by Application, Value (US$ Mn) and Volume (Units), 2018 - 2031
- 6.2.1. Key Highlights
  - 6.2.1.1. Microbial Diversity
  - 6.2.1.2. Bioremediation and degradation
  - 6.2.1.3. Bio surfactants and Antibiotics Production
  - 6.2.1.4. Clinical Diagnostics
  - 6.2.1.5. Others
6.3. North America Metagenomics Market Outlook, by End User, Value (US$ Mn) and Volume (Units), 2018 - 2031
- 6.3.1. Key Highlights
  - 6.3.1.1. Pharmaceutical Industries
  - 6.3.1.2. Research Laboratories
  - 6.3.1.3. Biotechnology Companies
  - 6.3.1.4. Pathology Laboratories
  - 6.3.1.5. Academic and Research Laboratories
  - 6.3.1.6. Hospitals
  - 6.3.1.7. Others (Environmental institutes, chemical companies etc.)
- 6.3.2. BPS Analysis/Market Attractiveness Analysis
6.4. North America Metagenomics Market Outlook, by Country, Value (US$ Mn) and Volume (Units), 2018 - 2031
- 6.4.1. Key Highlights
  - 6.4.1.1. U.S. Metagenomics Market by Service Type, Value (US$ Mn) and Volume (Units), 2018 - 2031
  - 6.4.1.2. U.S. Metagenomics Market by Specialty, Value (US$ Mn) and Volume (Units), 2018 - 2031
  - 6.4.1.3. U.S. Metagenomics Market by End User, Value (US$ Mn) and Volume (Units), 2018 - 2031
  - 6.4.1.4. Canada Metagenomics Market by Service Type, Value (US$ Mn) and Volume (Units), 2018 - 2031
  - 6.4.1.5. Canada Metagenomics Market by Specialty, Value (US$ Mn) and Volume (Units), 2018 - 2031
  - 6.4.1.6. Canada Metagenomics Market by End User, Value (US$ Mn) and Volume (Units), 2018 - 2031
- 6.4.2. BPS Analysis/Market Attractiveness Analysis

7. Europe Metagenomics Market Outlook, 2018 - 2031

7.1. Europe Metagenomics Market Outlook, by Product Types, Value (US$ Mn) and Volume (Units), 2018 - 2031
- 7.1.1. Key Highlights
  - 7.1.1.1. Library Preparation Kits
  - 7.1.1.2. Sample Extraction Kits
  - 7.1.1.3. Metagenomic Sequencing Kits
7.2. Europe Metagenomics Market Outlook, by Application, Value (US$ Mn) and Volume (Units), 2018 - 2031
- 7.2.1. Key Highlights
  - 7.2.1.1. Microbial Diversity
  - 7.2.1.2. Bioremediation and degradation
  - 7.2.1.3. Bio surfactants and Antibiotics Production
  - 7.2.1.4. Clinical Diagnostics
  - 7.2.1.5. Others
7.3. Europe Metagenomics Market Outlook, by End User, Value (US$ Mn) and Volume (Units), 2018 - 2031
- 7.3.1. Key Highlights
  - 7.3.1.1. Pharmaceutical Industries
  - 7.3.1.2. Research Laboratories
  - 7.3.1.3. Biotechnology Companies
  - 7.3.1.4. Pathology Laboratories
  - 7.3.1.5. Academic and Research Laboratories
  - 7.3.1.6. Hospitals
  - 7.3.1.7. Others (Environmental institutes, chemical companies etc.)
- 7.3.2. Attractiveness Analysis
7.4. Europe Metagenomics Market Outlook, by Country, Value (US$ Mn) and Volume (Units), 2018 - 2031
- 7.4.1. Key Highlights
  - 7.4.1.1. Germany Metagenomics Market by Service Type, Value (US$ Mn) and Volume (Units), 2018 - 2031
  - 7.4.1.2. Germany Metagenomics Market by Specialty, Value (US$ Mn) and Volume (Units), 2018 - 2031
  - 7.4.1.3. Germany Metagenomics Market by End User, Value (US$ Mn) and Volume (Units), 2018 - 2031
  - 7.4.1.4. U.K. Metagenomics Market by Service Type, Value (US$ Mn) and Volume (Units), 2018 - 2031
  - 7.4.1.5. U.K. Metagenomics Market by Specialty, Value (US$ Mn) and Volume (Units), 2018 - 2031
  - 7.4.1.6. U.K. Metagenomics Market by End User, Value (US$ Mn) and Volume (Units), 2018 - 2031
  - 7.4.1.7. France Metagenomics Market by Service Type, Value (US$ Mn) and Volume (Units), 2018 - 2031
  - 7.4.1.8. France Metagenomics Market by Specialty, Value (US$ Mn) and Volume (Units), 2018 - 2031
  - 7.4.1.9. France Metagenomics Market by End User, Value (US$ Mn) and Volume (Units), 2018 - 2031
  - 7.4.1.10. Italy Metagenomics Market by Service Type, Value (US$ Mn) and Volume (Units), 2018 - 2031
  - 7.4.1.11. Italy Metagenomics Market by Specialty, Value (US$ Mn) and Volume (Units), 2018 - 2031
  - 7.4.1.12. Italy Metagenomics Market by End User, Value (US$ Mn) and Volume (Units), 2018 - 2031
  - 7.4.1.13. Turkey Metagenomics Market by Service Type, Value (US$ Mn) and Volume (Units), 2018 - 2031
  - 7.4.1.14. Turkey Metagenomics Market by Specialty, Value (US$ Mn) and Volume (Units), 2018 - 2031
  - 7.4.1.15. Turkey Metagenomics Market by End User, Value (US$ Mn) and Volume (Units), 2018 - 2031
  - 7.4.1.16. Russia Metagenomics Market by Service Type, Value (US$ Mn) and Volume (Units), 2018 - 2031
  - 7.4.1.17. Russia Metagenomics Market by Specialty, Value (US$ Mn) and Volume (Units), 2018 - 2031
  - 7.4.1.18. Russia Metagenomics Market by End User, Value (US$ Mn) and Volume (Units), 2018 - 2031
  - 7.4.1.19. Rest of Europe Metagenomics Market by Service Type, Value (US$ Mn) and Volume (Units), 2018 - 2031
  - 7.4.1.20. Rest of Europe Metagenomics Market by Specialty, Value (US$ Mn) and Volume (Units), 2018 - 2031
  - 7.4.1.21. Rest of Europe Metagenomics Market by End User, Value (US$ Mn) and Volume (Units), 2018 - 2031
- 7.4.2. BPS Analysis/Market Attractiveness Analysis

8. Asia Pacific Metagenomics Market Outlook, 2018 - 2031

8.1. Asia Pacific Metagenomics Market Outlook, by Product Types, Value (US$ Mn) and Volume (Units), 2018 - 2031
- 8.1.1. Key Highlights
  - 8.1.1.1. Library Preparation Kits
  - 8.1.1.2. Sample Extraction Kits
  - 8.1.1.3. Metagenomic Sequencing Kits
8.2. Asia Pacific Metagenomics Market Outlook, by Application, Value (US$ Mn) and Volume (Units), 2018 - 2031
- 8.2.1. Key Highlights
  - 8.2.1.1. Microbial Diversity
  - 8.2.1.2. Bioremediation and degradation
  - 8.2.1.3. Bio surfactants and Antibiotics Production
  - 8.2.1.4. Clinical Diagnostics
  - 8.2.1.5. Others
8.3. Asia Pacific Metagenomics Market Outlook, by End User, Value (US$ Mn) and Volume (Units), 2018 - 2031
- 8.3.1. Key Highlights
  - 8.3.1.1. Pharmaceutical Industries
  - 8.3.1.2. Research Laboratories
  - 8.3.1.3. Biotechnology Companies
  - 8.3.1.4. Pathology Laboratories
  - 8.3.1.5. Academic and Research Laboratories
  - 8.3.1.6. Hospitals
  - 8.3.1.7. Others (Environmental institutes, chemical companies etc.)
- 8.3.2. BPS Analysis/Market Attractiveness Analysis
8.4. Asia Pacific Metagenomics Market Outlook, by Country, Value (US$ Mn) and Volume (Units), 2018 - 2031
- 8.4.1. Key Highlights
  - 8.4.1.1. China Metagenomics Market by Service Type, Value (US$ Mn) and Volume (Units), 2018 - 2031
  - 8.4.1.2. China Metagenomics Market by Specialty, Value (US$ Mn) and Volume (Units), 2018 - 2031
  - 8.4.1.3. China Metagenomics Market by End User, Value (US$ Mn) and Volume (Units), 2018 - 2031
  - 8.4.1.4. Japan Metagenomics Market by Service Type, Value (US$ Mn) and Volume (Units), 2018 - 2031
  - 8.4.1.5. Japan Metagenomics Market by Specialty, Value (US$ Mn) and Volume (Units), 2018 - 2031
  - 8.4.1.6. Japan Metagenomics Market by End User, Value (US$ Mn) and Volume (Units), 2018 - 2031
  - 8.4.1.7. South Korea Metagenomics Market by Service Type, Value (US$ Mn) and Volume (Units), 2018 - 2031
  - 8.4.1.8. South Korea Metagenomics Market by Specialty, Value (US$ Mn) and Volume (Units), 2018 - 2031
  - 8.4.1.9. South Korea Metagenomics Market by End User, Value (US$ Mn) and Volume (Units), 2018 - 2031
  - 8.4.1.10. India Metagenomics Market by Service Type, Value (US$ Mn) and Volume (Units), 2018 - 2031
  - 8.4.1.11. India Metagenomics Market by Specialty, Value (US$ Mn) and Volume (Units), 2018 - 2031
  - 8.4.1.12. India Metagenomics Market by End User, Value (US$ Mn) and Volume (Units), 2018 - 2031
  - 8.4.1.13. Southeast Asia Metagenomics Market by Service Type, Value (US$ Mn) and Volume (Units), 2018 - 2031
  - 8.4.1.14. Southeast Asia Metagenomics Market by Specialty, Value (US$ Mn) and Volume (Units), 2018 - 2031
  - 8.4.1.15. Southeast Asia Metagenomics Market by End User, Value (US$ Mn) and Volume (Units), 2018 - 2031
  - 8.4.1.16. Rest of Asia Pacific Metagenomics Market by Service Type, Value (US$ Mn) and Volume (Units), 2018 - 2031
  - 8.4.1.17. Rest of Asia Pacific Metagenomics Market by Specialty, Value (US$ Mn) and Volume (Units), 2018 - 2031
  - 8.4.1.18. Rest of Asia Pacific Metagenomics Market by End User, Value (US$ Mn) and Volume (Units), 2018 - 2031
- 8.4.2. BPS Analysis/Market Attractiveness Analysis

9. Latin America Metagenomics Market Outlook, 2018 - 2031

9.1. Latin America Metagenomics Market Outlook, by Product Types, Value (US$ Mn) and Volume (Units), 2018 - 2031
- 9.1.1. Key Highlights
  - 9.1.1.1. Library Preparation Kits
  - 9.1.1.2. Sample Extraction Kits
  - 9.1.1.3. Metagenomic Sequencing Kits
9.2. Latin America Metagenomics Market Outlook, by Application, Value (US$ Mn) and Volume (Units), 2018 - 2031
- 9.2.1. Key Highlights
  - 9.2.1.1. Microbial Diversity
  - 9.2.1.2. Bioremediation and degradation
  - 9.2.1.3. Bio surfactants and Antibiotics Production
  - 9.2.1.4. Clinical Diagnostics
  - 9.2.1.5. Others
9.3. Latin America Metagenomics Market Outlook, by End User, Value (US$ Mn) and Volume (Units), 2018 - 2031
- 9.3.1. Key Highlights
  - 9.3.1.1. Pharmaceutical Industries
  - 9.3.1.2. Research Laboratories
  - 9.3.1.3. Biotechnology Companies
  - 9.3.1.4. Pathology Laboratories
  - 9.3.1.5. Academic and Research Laboratories
  - 9.3.1.6. Hospitals
  - 9.3.1.7. Others (Environmental institutes, chemical companies etc.)
- 9.3.2. BPS Analysis/Market Attractiveness Analysis
9.4. Latin America Metagenomics Market Outlook, by Country, Value (US$ Mn) and Volume (Units), 2018 - 2031
- 9.4.1. Key Highlights
  - 9.4.1.1. Brazil Metagenomics Market by Service Type, Value (US$ Mn) and Volume (Units), 2018 - 2031
  - 9.4.1.2. Brazil Metagenomics Market by Specialty, Value (US$ Mn) and Volume (Units), 2018 - 2031
  - 9.4.1.3. Brazil Metagenomics Market by End User, Value (US$ Mn) and Volume (Units), 2018 - 2031
  - 9.4.1.4. Mexico Metagenomics Market by Service Type, Value (US$ Mn) and Volume (Units), 2018 - 2031
  - 9.4.1.5. Mexico Metagenomics Market by Specialty, Value (US$ Mn) and Volume (Units), 2018 - 2031
  - 9.4.1.6. Mexico Metagenomics Market by End User, Value (US$ Mn) and Volume (Units), 2018 - 2031
  - 9.4.1.7. Argentina Metagenomics Market by Service Type, Value (US$ Mn) and Volume (Units), 2018 - 2031
  - 9.4.1.8. Argentina Metagenomics Market by Specialty, Value (US$ Mn) and Volume (Units), 2018 - 2031
  - 9.4.1.9. Argentina Metagenomics Market by End User, Value (US$ Mn) and Volume (Units), 2018 - 2031
  - 9.4.1.10. Rest of Latin America Metagenomics Market by Service Type, Value (US$ Mn) and Volume (Units), 2018 - 2031
  - 9.4.1.11. Rest of Latin America Metagenomics Market by Specialty, Value (US$ Mn) and Volume (Units), 2018 - 2031
  - 9.4.1.12. Rest of Latin America Metagenomics Market by End User, Value (US$ Mn) and Volume (Units), 2018 - 2031
- 9.4.2. BPS Analysis/Market Attractiveness Analysis

10. Middle East & Africa Metagenomics Market Outlook, 2018 - 2031

10.1. Middle East & Africa Metagenomics Market Outlook, by Product Types, Value (US$ Mn) and Volume (Units), 2018 - 2031
- 10.1.1. Key Highlights
  - 10.1.1.1. Library Preparation Kits
  - 10.1.1.2. Sample Extraction Kits
  - 10.1.1.3. Metagenomic Sequencing Kits
10.2. Middle East & Africa Metagenomics Market Outlook, by Application, Value (US$ Mn) and Volume (Units), 2018 - 2031
- 10.2.1. Key Highlights
  - 10.2.1.1. Microbial Diversity
  - 10.2.1.2. Bioremediation and degradation
  - 10.2.1.3. Bio surfactants and Antibiotics Production
  - 10.2.1.4. Clinical Diagnostics
  - 10.2.1.5. Others
10.3. Middle East & Africa Metagenomics Market Outlook, by End User, Value (US$ Mn) and Volume (Units), 2018 - 2031
- 10.3.1. Key Highlights
  - 10.3.1.1. Pharmaceutical Industries
  - 10.3.1.2. Research Laboratories
  - 10.3.1.3. Biotechnology Companies
  - 10.3.1.4. Pathology Laboratories
  - 10.3.1.5. Academic and Research Laboratories
  - 10.3.1.6. Hospitals
  - 10.3.1.7. Others (Environmental institutes, chemical companies etc.)
- 10.3.2. BPS Analysis/Market Attractiveness Analysis
10.4. Middle East & Africa Metagenomics Market Outlook, by Country, Value (US$ Mn) and Volume (Units), 2018 - 2031
- 10.4.1. Key Highlights
  - 10.4.1.1. GCC Metagenomics Market by Service Type, Value (US$ Mn) and Volume (Units), 2018 - 2031
  - 10.4.1.2. GCC Metagenomics Market by Specialty, Value (US$ Mn) and Volume (Units), 2018 - 2031
  - 10.4.1.3. GCC Metagenomics Market by End User, Value (US$ Mn) and Volume (Units), 2018 - 2031
  - 10.4.1.4. South Africa Metagenomics Market by Service Type, Value (US$ Mn) and Volume (Units), 2018 - 2031
  - 10.4.1.5. South Africa Metagenomics Market by Specialty, Value (US$ Mn) and Volume (Units), 2018 - 2031
  - 10.4.1.6. South Africa Metagenomics Market by End User, Value (US$ Mn) and Volume (Units), 2018 - 2031
  - 10.4.1.7. Egypt Metagenomics Market by Service Type, Value (US$ Mn) and Volume (Units), 2018 - 2031
  - 10.4.1.8. Egypt Metagenomics Market by Specialty, Value (US$ Mn) and Volume (Units), 2018 - 2031
  - 10.4.1.9. Egypt Metagenomics Market by End User, Value (US$ Mn) and Volume (Units), 2018 - 2031
  - 10.4.1.10. Nigeria Metagenomics Market by Service Type, Value (US$ Mn) and Volume (Units), 2018 - 2031
  - 10.4.1.11. Nigeria Metagenomics Market by Specialty, Value (US$ Mn) and Volume (Units), 2018 - 2031
  - 10.4.1.12. Nigeria Metagenomics Market by End User, Value (US$ Mn) and Volume (Units), 2018 - 2031
  - 10.4.1.13. Rest of Middle East & Africa Metagenomics Market by Service Type, Value (US$ Mn) and Volume (Units), 2018 - 2031
  - 10.4.1.14. Rest of Middle East & Africa Metagenomics Market by Specialty, Value (US$ Mn) and Volume (Units), 2018 - 2031
  - 10.4.1.15. Rest of Middle East & Africa Metagenomics Market by End User, Value (US$ Mn) and Volume (Units), 2018 - 2031
- 10.4.2. BPS Analysis/Market Attractiveness Analysis

11. Competitive Landscape

11.1. By End User vs by Product Types Heatmap
11.2. Company Market Share Analysis, 2023
11.3. Competitive Dashboard
11.4. Company Profiles
- 11.4.1. Illumina Inc
  - 11.4.1.1. Company Overview
  - 11.4.1.2. Product Portfolio
  - 11.4.1.3. Financial Overview
  - 11.4.1.4. Business Strategies and Development
- 11.4.2. Perkin Elmer Inc.
  - 11.4.2.1. Company Overview
  - 11.4.2.2. Product Portfolio
  - 11.4.2.3. Financial Overview
  - 11.4.2.4. Business Strategies and Development
- 11.4.3. Trivitron Healthcare Pvt. Ltd.
  - 11.4.3.1. Company Overview
  - 11.4.3.2. Product Portfolio
  - 11.4.3.3. Financial Overview
  - 11.4.3.4. Business Strategies and Development
- 11.4.4. Qiagen N.V.
  - 11.4.4.1. Company Overview
  - 11.4.4.2. Product Portfolio
  - 11.4.4.3. Financial Overview
  - 11.4.4.4. Business Strategies and Development
- 11.4.5. Thermo Fisher Scientific
  - 11.4.5.1. Company Overview
  - 11.4.5.2. Product Portfolio
  - 11.4.5.3. Financial Overview
  - 11.4.5.4. Business Strategies and Development
- 11.4.6. SymBio Scientific Pvt. Ltd
  - 11.4.6.1. Company Overview
  - 11.4.6.2. Product Portfolio
  - 11.4.6.3. Financial Overview
  - 11.4.6.4. Business Strategies and Development
- 11.4.7. Infobio
  - 11.4.7.1. Company Overview
  - 11.4.7.2. Product Portfolio
  - 11.4.7.3. Financial Overview
  - 11.4.7.4. Business Strategies and Development
- 11.4.8. Bio-Rad Laboratories
  - 11.4.8.1. Company Overview
  - 11.4.8.2. Product Portfolio
  - 11.4.8.3. Financial Overview
  - 11.4.8.4. Business Strategies and Development
- 11.4.9. Merck KgaA
  - 11.4.9.1. Company Overview
  - 11.4.9.2. Product Portfolio
  - 11.4.9.3. Financial Overview
  - 11.4.9.4. Business Strategies and Development
- 11.4.10. Promega Corporation
  - 11.4.10.1. Company Overview
  - 11.4.10.2. Product Portfolio
  - 11.4.10.3. Financial Overview
  - 11.4.10.4. Business Strategies and Development

12. Appendix

12.1. Research Methodology
12.2. Report Assumptions
12.3. Acronyms and Abbreviations